Clarity secures IND from FDA for radiotracer for prostate cancer
Clarity Pharmaceuticals has secured investigational new drug approval (IND...Read more on AuntMinnie.comRelated Reading:
Clarity treats first patient in COBRA trial
Clarity launching trial for prostate cancer therapy
Clarity hits milestone in study of radiopharmaceutical
NorthStar partners with Clarity, Monopar
FDA grants rare disease designation to Clarity agent
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Grants | Investigational New Drugs | Prostate Cancer | Radiology | Rare Diseases | Study